Business Description
Redcare Pharmacy NV
ISIN : NL0012044747
Compare
Compare
Traded in other countries / regions
RDC.Germany0RJT.UKSAEYY.USASHOP.Austria IPO Date
2016-10-13Description
Redcare Pharmacy NV operates an online pharmacy store. Its product portfolio is focused on prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company's operating segment includes DACH and International. It generates maximum revenue domestically from the DACH segment. Geographically, it has a presence in Germany, Austria, Switzerland, Netherlands, Belgium, Spain, France, and Italy.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.95 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.48 | |||||
| Debt-to-EBITDA | 3.99 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 5.64 | |||||
| Beneish M-Score | -2.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.6 | |||||
| 3-Year EBITDA Growth Rate | 51.8 | |||||
| 3-Year EPS without NRI Growth Rate | -3.7 | |||||
| 3-Year Book Growth Rate | 3.5 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 24.61 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.2 | |||||
| 9-Day RSI | 69.86 | |||||
| 14-Day RSI | 67.76 | |||||
| 6-1 Month Momentum % | 3.54 | |||||
| 12-1 Month Momentum % | 23.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.12 | |||||
| Quick Ratio | 1.57 | |||||
| Cash Ratio | 0.95 | |||||
| Days Inventory | 29.1 | |||||
| Days Sales Outstanding | 19.21 | |||||
| Days Payable | 36.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.5 | |||||
| Shareholder Yield % | 0.44 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 23.16 | |||||
| Operating Margin % | -0.79 | |||||
| Net Margin % | -0.44 | |||||
| FCF Margin % | -0.36 | |||||
| ROE % | -1.8 | |||||
| ROA % | -0.89 | |||||
| ROIC % | -2.03 | |||||
| 3-Year ROIIC % | -4.66 | |||||
| ROC (Joel Greenblatt) % | -3.12 | |||||
| ROCE % | -0.54 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 255.88 | |||||
| PS Ratio | 1.39 | |||||
| PB Ratio | 5.76 | |||||
| Price-to-Tangible-Book | 31.15 | |||||
| Price-to-Operating-Cash-Flow | 91.12 | |||||
| EV-to-EBIT | -667.98 | |||||
| EV-to-Forward-EBIT | 118.22 | |||||
| EV-to-EBITDA | 48.51 | |||||
| EV-to-Forward-EBITDA | 39.47 | |||||
| EV-to-Revenue | 1.4 | |||||
| EV-to-Forward-Revenue | 1.06 | |||||
| EV-to-FCF | -384.39 | |||||
| Price-to-Projected-FCF | 69.91 | |||||
| Price-to-Net-Current-Asset-Value | 676.82 | |||||
| Earnings Yield (Greenblatt) % | -0.15 | |||||
| FCF Yield % | -0.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Redcare Pharmacy NV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2,127.708 | ||
| EPS (TTM) (€) | -0.43 | ||
| Beta | 1.21 | ||
| Volatility % | 42.61 | ||
| 14-Day RSI | 67.76 | ||
| 14-Day ATR (€) | 4.760994 | ||
| 20-Day SMA (€) | 141.07 | ||
| 12-1 Month Momentum % | 23.83 | ||
| 52-Week Range (€) | 96.15 - 153.6 | ||
| Shares Outstanding (Mil) | 20.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Redcare Pharmacy NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Redcare Pharmacy NV Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Redcare Pharmacy NV Frequently Asked Questions
What is Redcare Pharmacy NV(STU:RDC)'s stock price today?
The current price of STU:RDC is €148.90. The 52 week high of STU:RDC is €153.60 and 52 week low is €96.15.
When is next earnings date of Redcare Pharmacy NV(STU:RDC)?
The next earnings date of Redcare Pharmacy NV(STU:RDC) is .
Does Redcare Pharmacy NV(STU:RDC) pay dividends? If so, how much?
Redcare Pharmacy NV(STU:RDC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers